The world of Drug Safety and Pharmacovigilance is undergoing dramatic change from simple adverse event reporting to comprehensive signal and benefit-risk management processes. In this course, attendees will be introduced to the core aspects of best practices by industry experts. The short course will mix its lectures with practical demonstrations and roundtable discussions.
The Drug Information Association (DIA) 2020 Global Annual Meeting, designated “Patients Included” reflects DIA’s commitment to incorporating the experience of patients as experts in living with their condition while ensuring they are neither excluded nor exploited.
We are delighted to announce that Dr. Nancy Pire-Smerkanich has been selected to receive the 2020 Drug Information Association (DIA) Inspire Award for Excellence in Service in the Americas Region.